Biolin Scientific acquires the key patent protecting multi-hole, high-throughput ion channel screening

NewsGuard 100/100 Score

Biolin Scientific today announces the acquisition of a key patent related to performing multi-hole, high-throughput ion channel screening.

“We are pleased to strengthen our position as the leaders in high-throughput ion channel screening and this patent, along with Sophion Qube™, our new instrument platform for high-through put screening, will enable us to screen hundreds of thousands of compounds in our continuing efforts to support and speed up drug discovery”, says Morten Sunesen, VP of Drug Discovery Systems at Biolin Scientific.

The patent describes a method for ensuring high data quality by analyzing multiple cells and thus multiple sets of ion channels under one experimental condition, thus providing extremely high data quality and a truly high throughput screening method.

Biolin Scientific CEO, Johan von Heijne states, “This acquisition underlines our commitment to moving further into high throughput ion channel screening and is an important support and milestone related to the recent launch of the Sophion Qube ion channel screening platform. Additionally, this acquisition affirms our intent to vigorously protect and expand our broad range of intellectual property and to invest in new technologies.”

Biolin Scientific is a leading Nordic instrumentation company with roots in Sweden, Denmark and Finland. Our customers include companies working with pharmaceuticals, energy, chemicals, and advanced materials, as well as academic and governmental research institutes. Our precision instruments help discover better drugs faster, develop better solutions for energy and materials, and perform research at the frontiers of science and technology.

Biolin Scientific proprietary systems are based on nanotechnology and advanced measurement techniques. They have earned leadership in several industries through our commitment to scientific excellence and continuous product development.

Our commitment to customer service and application support is a key feature of our operations. We focus on working together with customers and building long-standing relations. Today, Biolin Scientific provides products and services in more than 70 countries around the world.

Source: Biolin Scientific

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rising antibiotic resistance prompts shift to ecological research strategies in infection control